Minimal clinically important improvement/difference (MCII/MCID) and patient acceptable symptom state (PASS): what do these concepts mean?
- 1 November 2007
- journal article
- review article
- Published by BMJ in Annals Of The Rheumatic Diseases
- Vol. 66 (Supplement), iii40-iii41
- https://doi.org/10.1136/ard.2007.079798
Abstract
An increasing focus has over recent years been directed to the use of categorical endpoints to define response, i.e. to define cut-points for important improvement and/or acceptable clinical state. The levels of Minimal Clinically Important Improvement (MCII) are typically defined according to the patients perception of what is an important improvement. It can be defined as the smallest change in measurement that signifies an important improvement. MCII signifies an improvement of relevance in a clinical trial, or the minimal meaningful change at an individual level. The Minimal Clinically Important Difference (MCID) may reflect either an improvement or a worsening. Patient Acceptable Symptom State (PASS) has been defined as the highest level of symptom beyond which patients consider themselves well. Cut-points for MCII and PASS are usually identified through two different statistical approaches. The 75th percentage approach identifies the cut-point corresponding to the 75 percentile of the scores for improvement in patients who report an important improvement by the anchoring question. Applying receiver operating characteristic (ROC) curves allows for choosing the threshold that is the best compromise between sensitivity and specificity for each outcome criterion. The identified cut-points for MCII and PASS may easily be incorporated as endpoints in clinical trials, and will provide information about the proportion of patients that achieve an improvement exceeding the level accepted as MCII and achieve a state accepted as PASS.Keywords
This publication has 11 references indexed in Scilit:
- Minimal clinically important improvement and patient acceptable symptom state for subjective outcome measures in rheumatic disorders.2007
- Radiological damage in patients with rheumatoid arthritis on sustained remissionAnnals Of The Rheumatic Diseases, 2007
- Stability of the patient acceptable symptomatic state over time in outcome criteria in ankylosing spondylitisArthritis Care & Research, 2006
- Feeling good rather than feeling better matters more to patientsArthritis Care & Research, 2006
- Minimal clinically important difference, low disease activity state, and patient acceptable symptom state: methodological issues.2005
- It's good to feel better but it's better to feel good.2005
- Evaluation of clinically relevant states in patient reported outcomes in knee and hip osteoarthritis: the patient acceptable symptom stateAnnals Of The Rheumatic Diseases, 2005
- Evaluation of clinically relevant changes in patient reported outcomes in knee and hip osteoarthritis: the minimal clinically important improvementAnnals Of The Rheumatic Diseases, 2005
- Minimal clinically important differences: review of methods.2001
- Minimal clinically important difference module: summary, recommendations, and research agenda.2001